Lee Rauch's most recent trade in Ensysce Biosciences Inc was a trade of 15,000 Stock Option done . Disclosure was reported to the exchange on June 23, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ensysce Biosciences Inc | Lee Rauch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 15,000 | 35,000 | - | - | Stock Option | |
| Viridian Therapeutics Inc | Lee Rauch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 15,000 | 15,000 | - | - | Employee Stock Option (right to buy) | |
| Viridian Therapeutics Inc | Lee Rauch | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2020 | 900,000 | 900,000 | - | - | Stock Option (right to buy) |